COMPILATION OF AUTHORITATIVE INTERVIEWS ON COVID-19 THERAPIES AND PREGNANCY
The Omicron Whirlwind: A Conversation with Eric Topol - The Current and Future State of the Pandemic.
Professor and Chair of the Department of Medicine at the University of California, San Francisco (UCSF) interviews Eric Topol MD—founder and director of the Scripps Research Translational Institute, senior consultant at the Division of Cardiovascular Diseases at Scripps Clinic in La Jolla, California, and editor-in-chief of Medscape and theheart.org. In addition to the various COVID-19 treatments, risk groups in which they are beneficial in preventing severe disease (which include pregnant women), and the relevant scientific publications in the context of the omicron variant, the discussion includes related issues, such as vaccination and school closures.
Dr. Michael Anderson, senior advisor at the US Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response in Washington, D.C.
Interviewed June 24, 2021 by Todd Unger, Chief Experience Officer of the American Medical Association. Topic is the effectiveness of monoclonal antibodies (mAbs)for COVID-19. During the interview, Anderson explains that emergency use authorization for mAb treatment for COVID-19 was expanded to include pregnant women, due to pregnancy being among the risk factors for the development of severe COVID-19.
University of Alabama at Birmingham (UAB) —hosted media interview Q & A with two experts
MD, Assistant Professor of Obstetrics and Gynecology at UAB and Jodie Dionne, MD, Associate Director of Global Health in the UAB Center for Women’s Reproductive Health and Associate Professor in the Division of Infectious Diseases— along with a physician who gave birth during 2021 and received her COVID-19 vaccination during pregnancy, Jessica Grayson MD, Assistant Professor of Otolaryngology, also at UAB. The discussion focusses on the efficacy and safety of COVID-19 vaccination, but there is one point at which Dr. Dionne answers a question from media about monoclonal antibody therapy during pregnancy (~18:07-19:17).
Using Paxlovid Effectively
Interviewed by media, Eric Arlia, Vice President of System Pharmacy, Hartford HealthCare, Connecticut, explains Paxlovid, the Pfizer oral medication for COVID-19.